<VariationArchive RecordType="classified" VariationID="242926" VariationName="NM_015359.6(SLC39A14):c.477_478del (p.Ser160fs)" VariationType="Deletion" Accession="VCV000242926" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-10-01" DateCreated="2016-08-22" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="244028" VariationID="242926">
      <GeneList>
        <Gene Symbol="SLC39A14" FullName="solute carrier family 39 member 14" GeneID="23516" HGNC_ID="HGNC:20858" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="22367278" stop="22434129" display_start="22367278" display_stop="22434129" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="22224761" stop="22291641" display_start="22224761" display_stop="22291641" Strand="+" />
          </Location>
          <OMIM>608736</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015359.6(SLC39A14):c.477_478del (p.Ser160fs)</Name>
      <CanonicalSPDI>NC_000008.11:22409964:CA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8p21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="22409965" stop="22409966" display_start="22409965" display_stop="22409966" variantLength="2" positionVCF="22409964" referenceAlleleVCF="TCA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="22267478" stop="22267479" display_start="22267478" display_stop="22267479" variantLength="2" positionVCF="22267477" referenceAlleleVCF="TCA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>S160fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.22267478_22267479del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.22267478_22267479del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.22409965_22409966del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.22409965_22409966del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_054890.1" sequenceAccession="NG_054890" sequenceVersion="1" change="g.47717_47718del">
            <Expression>NG_054890.1:g.47717_47718del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015359.6" sequenceAccession="NM_015359" sequenceVersion="6" change="c.477_478del" MANEPlusClinical="true">
            <Expression>NM_015359.6:c.477_478del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056174.2" sequenceAccession="NP_056174" sequenceVersion="2" change="p.Ser160fs">
            <Expression>NP_056174.2:p.Ser160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001135154.3" sequenceAccession="NM_001135154" sequenceVersion="3" change="c.457+1469_457+1470del">
            <Expression>NM_001135154.3:c.457+1469_457+1470del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351656.2" sequenceAccession="NM_001351656" sequenceVersion="2" change="c.457+1469_457+1470del">
            <Expression>NM_001351656.2:c.457+1469_457+1470del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351657.2" sequenceAccession="NM_001351657" sequenceVersion="2" change="c.487+1469_487+1470del">
            <Expression>NM_001351657.2:c.487+1469_487+1470del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351655.2" sequenceAccession="NM_001351655" sequenceVersion="2" change="c.457+1469_457+1470del">
            <Expression>NM_001351655.2:c.457+1469_457+1470del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351658.2" sequenceAccession="NM_001351658" sequenceVersion="2" change="c.487+1469_487+1470del">
            <Expression>NM_001351658.2:c.487+1469_487+1470del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128431.4" sequenceAccession="NM_001128431" sequenceVersion="4" change="c.457+1469_457+1470del" MANESelect="true">
            <Expression>NM_001128431.4:c.457+1469_457+1470del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001135153.3" sequenceAccession="NM_001135153" sequenceVersion="3" change="c.457+1469_457+1470del">
            <Expression>NM_001135153.3:c.457+1469_457+1470del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351660.2" sequenceAccession="NM_001351660" sequenceVersion="2" change="c.457+1469_457+1470del">
            <Expression>NM_001351660.2:c.457+1469_457+1470del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351659.2" sequenceAccession="NM_001351659" sequenceVersion="2" change="c.487+1469_487+1470del">
            <Expression>NM_001351659.2:c.487+1469_487+1470del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10584029" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608736.0003" DB="OMIM" />
        <XRef Type="rs" ID="879253765" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015359.6(SLC39A14):c.477_478del (p.Ser160fs) AND Hypermanganesemia with dystonia 2" Accession="RCV000234924" Version="5">
        <ClassifiedConditionList TraitSetID="31214">
          <ClassifiedCondition DB="MedGen" ID="C4310765">Hypermanganesemia with dystonia 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2018-05-02" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-05-02" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-08-22" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Tuschl, K. Personal Communication. 2016. London, U.K.</CitationText>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">28541650</ID>
          <ID Source="BookShelf">NBK431123</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="31214" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="35747" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypermanganesemia with dystonia 2</ElementValue>
                <XRef ID="MONDO:0014864" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HMNDYT2</ElementValue>
                <XRef Type="MIM" ID="617013" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SLC39A14 deficiency is characterized by evidence between ages six months and three years of delay or loss of motor developmental milestones (e.g., delayed walking, gait disturbance). Early in the disease course, children show axial hypotonia followed by dystonia, spasticity, dysarthria, bulbar dysfunction, and signs of parkinsonism including bradykinesia, hypomimia, and tremor. By the end of the first decade they develop severe, generalized, pharmaco-resistant dystonia, limb contractures, and scoliosis, and lose independent ambulation. Cognitive impairment appears to be less prominent than motor disability. Some affected children have succumbed in their first decade due to secondary complications such as respiratory infections.</Attribute>
                <XRef ID="NBK431123" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28541650</ID>
                <ID Source="BookShelf">NBK431123</ID>
              </Citation>
              <XRef ID="521406" DB="Orphanet" />
              <XRef ID="C4310765" DB="MedGen" />
              <XRef ID="MONDO:0014864" DB="MONDO" />
              <XRef Type="MIM" ID="617013" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="556797" SubmissionDate="2018-05-02" DateLastUpdated="2018-05-05" DateCreated="2016-07-10">
        <ClinVarSubmissionID localKey="608736.0003_HYPERMANGANESEMIA WITH DYSTONIA 2" title="SLC39A14, 2-BP DEL, NT477_HYPERMANGANESEMIA WITH DYSTONIA 2" />
        <ClinVarAccession Accession="SCV000292247" DateUpdated="2018-05-05" DateCreated="2016-07-10" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-05-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a girl (family C), born of consanguineous Indian parents, with hypermanganesemia with dystonia-2 (HMNDYT2; 617013), Tuschl et al. (2016) identified a homozygous 2-bp deletion (c.477_478del, NM_015359.4) in exon 4A of the SLC39A14 gene, resulting in a frameshift and premature termination (Ser160CysfsTer5). The mutation, which was found by Sanger sequencing, was not found in the dbSNP (build 132), 1000 Genomes Project, or ExAC databases; the unaffected parents were heterozygous for the mutation. The mutation affected only isoform 2 of the gene, but the patient's phenotype was similar to patients with other mutations. However, this patient responded well to chelation therapy.</Attribute>
              <Citation>
                <CitationText>Tuschl, K. Personal Communication. 2016. London, U.K.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="617013" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC39A14" />
          </GeneList>
          <Name>SLC39A14, 2-BP DEL, NT477</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, NT477</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608736.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPERMANGANESEMIA WITH DYSTONIA 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1195316" SubmissionDate="2017-03-13" DateLastUpdated="2022-10-01" DateCreated="2016-08-22">
        <ClinVarSubmissionID localKey="NM_015359.4:c.477_478delCA|OMIM:617013" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000612141" DateUpdated="2022-10-01" DateCreated="2016-08-22" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="BookShelf">NBK431123</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC39A14" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_056174.2:p.Ser160Cysfs*5</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015359.4:c.477_478delCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4310765" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Abbrev="GeneReviews" Type="review">
          <ID Source="PubMed">28541650</ID>
          <ID Source="BookShelf">NBK431123</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1195316" TraitType="Disease" MappingType="XRef" MappingValue="C4310765" MappingRef="MedGen">
        <MedGen CUI="C4310765" Name="Hypermanganesemia with dystonia 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="556797" TraitType="Disease" MappingType="Name" MappingValue="HYPERMANGANESEMIA WITH DYSTONIA 2" MappingRef="Preferred">
        <MedGen CUI="C4310765" Name="Hypermanganesemia with dystonia 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

